X-110679374-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001143981.2(CHRDL1):āc.1208A>Gā(p.Glu403Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000249 in 1,206,817 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001143981.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHRDL1 | NM_001143981.2 | c.1208A>G | p.Glu403Gly | missense_variant | 11/12 | ENST00000372042.6 | NP_001137453.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHRDL1 | ENST00000372042.6 | c.1208A>G | p.Glu403Gly | missense_variant | 11/12 | 2 | NM_001143981.2 | ENSP00000361112.1 |
Frequencies
GnomAD3 genomes AF: 0.00000892 AC: 1AN: 112048Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34240
GnomAD4 exome AF: 0.00000183 AC: 2AN: 1094769Hom.: 0 Cov.: 28 AF XY: 0.00 AC XY: 0AN XY: 360273
GnomAD4 genome AF: 0.00000892 AC: 1AN: 112048Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34240
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 17, 2024 | The c.1208A>G (p.E403G) alteration is located in exon 11 (coding exon 10) of the CHRDL1 gene. This alteration results from a A to G substitution at nucleotide position 1208, causing the glutamic acid (E) at amino acid position 403 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at